1186579-82-7 Usage
Explanation
Different sources of media describe the Explanation of 1186579-82-7 differently. You can refer to the following data:
1. This is the chemical name of the compound, which describes its structure and composition.
2. The compound is derived from ethyl methanesulfonate, which is an alkylating agent used in mutagenesis studies.
3. The compound contains multiple ethoxy groups (OCH2CH3) in its structure, which can influence its reactivity and properties.
4. The compound includes a tert-butoxycarbonylamino group (OC(CH3)3N), which can affect its reactivity and stability.
5. The compound's structure is complex due to the presence of multiple ethoxy groups and a tert-butoxycarbonylamino moiety.
6. The compound's structure suggests that it may be a versatile reagent for the modification of organic molecules.
7. The presence of multiple alkylor alkoxy-groups in the compound suggests potential applications in the synthesis of polymers, surfactants, or other compounds requiring such groups.
8. The exact properties and potential uses of this compound would need additional research and investigation to be fully understood.
Derivative
Ethyl methanesulfonate
Ethoxy groups
Multiple
Tert-butoxycarbonylamino moiety
Present
Complexity
High
Versatility
Potential
Applications
Synthesis of polymers, surfactants, or other compounds
Further investigation
Required
Check Digit Verification of cas no
The CAS Registry Mumber 1186579-82-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,6,5,7 and 9 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1186579-82:
(9*1)+(8*1)+(7*8)+(6*6)+(5*5)+(4*7)+(3*9)+(2*8)+(1*2)=207
207 % 10 = 7
So 1186579-82-7 is a valid CAS Registry Number.
1186579-82-7Relevant articles and documents
LDV peptidomimetics equipped with biotinylated spacer-arms: Synthesis and biological evaluation on CCRF-CEM cell line
Gérard, Estelle,Meulle, Aline,Feron, Olivier,Marchand-Brynaert, Jacqueline
, p. 586 - 590 (2012/03/26)
The tripeptide Leu-Asp-Val (LDV) is known to bind α4β 1 integrin in leukemia cells. Here we have synthesized a LDV peptidomimetic equipped with a biotin-conjugated spacer-arm. Compound 9 acts as an inhibitor of the α4β1 integrin in an adhesion assay using fluorescently labeled, α4β 1 integrin-expressing leukemia CCRF-CEM cells. Furthermore, when bound to neutravidin-coated plates, compound 9 could capture CCRF-CEM cells. Such biotin-conjugated LDV peptidomimetic may thus represent a novel tool for biotechnological applications using avidin interaction for leukapheresis or leukemia cell targeting.
